Sumatriptan Succinate Injection
Product Images NDC 47335-276

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 47335-276). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Device-label (Device Label)

Label for Sumatriptan Injection, USP 6 mg/0.5 mL by Sun Pharmaceutical Industries, Inc. This subcutaneous injection includes instructions for use with illustrations showing needle shield removal, pressing the syringe at a right angle, releasing the blue button, and lifting the autoinjector. The label states Rx only, includes storage instructions, and identifies the product as a sterile, nonpyrogenic prefilled 0.5 mL syringe containing 6 mg of sumatriptan.*

FDA Label Image

Figure1 (Figure1)

A Kaplan-Meier survivorship plot showing time to relief of cluster headache from time of injection for Sumatriptan versus placebo. The x-axis represents time in minutes (0 to 25), and the y-axis shows the estimated percentage of patients with relief (0 to 100%). Two lines depict results for placebo (n=127) and Sumatriptan (n=131), with Sumatriptan showing a higher and faster percentage of patients experiencing relief over time.*

FDA Label Image

How-to-use-figure1 (How To Use Figure1)

An instructional diagram of a Sumatriptan Succinate subcutaneous injection pen showing key parts: a white needle shield on the left, a clear inspection window in the middle, a barrel, and a blue activation button on the right.*

FDA Label Image

How-to-use-figure2 (How To Use Figure2)

Illustration showing appropriate injection sites for Sumatriptan Succinate subcutaneous injection. The left image highlights the outer thigh, and the right image highlights the upper arm, with red circles indicating specific injection areas.*

FDA Label Image

How-to-use-figure3 (How To Use Figure3)

An instructional illustration showing hands operating a Sumatriptan Succinate subcutaneous injection pen. The image labels the white needle shield and safety needle cover and indicates how to pull the needle shield straight off before use.*

FDA Label Image

How-to-use-figure4 (How To Use Figure4)

An instructional illustration showing hands demonstrating the use of the Sumatriptan Succinate subcutaneous injection device. It depicts how to properly position and handle the device with the safety needle cover flush with the tip of the barrel, then the cover moved out, and finally the cover fully retracted, indicating steps for safe injection preparation.*

FDA Label Image

How-to-use-figure5 (How To Use Figure5)

An instructional diagram showing three steps to use a Sumatriptan Succinate 6 mg/0.5 mL subcutaneous injection pen. The first frame instructs to press the top of the pen until a click is heard, the second frame shows the release of pressure, and the third frame indicates the needle safety cover extending over the needle with a blue inspection window visible and a stopwatch icon suggesting timing.*

FDA Label Image

How-to-use-figure6 (How To Use Figure6)

An instructional illustration showing a Sumatriptan Succinate subcutaneous injection device in three stages: before use with a white needle shield attached, before use without the needle shield, and after use with the needle safety cover folded down over the needle.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of sumatriptan succinate, illustrating the molecular arrangement including a sulfonamide group, an indole ring, and succinate moiety.*

FDA Label Image

Sumatriptan-carton (Sumatriptan Carton)

Label for Sumatriptan Injection, USP 6 mg/0.5 mL, a subcutaneous injection in a package containing 2 prefilled 0.5 mL syringes. The label states Rx only and highlights subcutaneous injection use in red text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.